This year’s Liver Meeting will be the 70th annual meeting of the American Association for the Study of Liver Diseases (AASLD) and will bring together thousands of hepatologists and hepatology health professionals from across the nation and around the world. This year’s meeting will be held at the Hynes Convention Center in Boston, MA from November 9th to November 11th.
Throughout the conference, Visikol will be showcasing its 3D cell culture models and assays that are designed to assess general liver toxicity as well as liver disease progression. Specifically, Visikol has developed several liver 3D cell culture models and assays for assessing NASH and NAFLD disease progression and the amelioration thereof. To learn more about these assays, stop by Visikol’s booth or check out its poster on assessing fibrosis (poster #2284).
